Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olaparib in septic shock
RBR-8xdc8yzPhase 2Not yet recruiting
- Sponsor
- Escola Paulista de Medicina
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of olaparib in septic shock (2 arms), sponsored by Escola Paulista de Medicina. Planned start Feb 2023; status: not yet recruiting.
02
Drugs
olaparib
03
Conditions
septic shock
Beyond the preview
Go deeper on RBR-8xdc8yz.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8xdc8yz.